Skip to main content
Premium Trial:

Request an Annual Quote

California Precision Medicine Advisory Committee

California Gov. Edmund "Jerry" Brown has created the Governor's Advisory Committee on Precision Medicine and name some well-known figures to the 14-member panel. The committee will advise the governor's office on all matters related to precision medicine and make recommendations for statewide policy. Founding members are: 

  • Tomás Aragón, health officer of the City and County of San Francisco
  • Atul Butte, principal investigator of the California Initiative to Advance Precision Medicine at UC San Francisco
  • John Carpten, chair of the Department of Translational Genomics at the University of Southern California Keck School of Medicine
  • Jay Gellert, former president and CEO of Health Net
  • Kim Goodwin, author of "Designing for the Digital Age"
  • Stephen Lockhart, chief medical officer of Sutter Health
  • Kelsey Martin, dean of the David Geffen School of Medicine at UCLA
  • Mary Maxon, associate laboratory director for biosciences at Lawrence Berkeley National Laboratory
  • Jessica Mega, chief medical officer of Verily Life Sciences
  • Jill Mesirov, associate vice chancellor for computational health at UC San Diego School of Medicine
  • Frederick Meyers, associate dean for precision medicine at UC Davis Health
  • Arnold Milstein, director of the Clinical Excellence Research Center at Stanford University
  • Hakan Sakul, vice president of diagnostics at Pfizer
  • Sue Siegel, CEO of GE Ventures. 
The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.